List of medicines under additional monitoring
https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20 – 23 February 2023
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023
Human medicines: highlights of 2022
https://www.ema.europa.eu/en/news/human-medicines-highlights-2022
Welcome to the team!
The Pharmya Team is happy to welcome Manel, our new PV Expert trainee!
The European Medicines Agency (EMA) is delivering a Product Management Service (PMS) and a Substance Management Service (SMS) to support regulatory activities in the European Union (EU)
https://www.ema.europa.eu/en/human-regulatory/research-development/data-medicines-iso-idmp-standards/spor-master-data/substance-product-data-management-services?fbclid=IwAR2n_D1C_FF0oRphglmchOODcHaeMU-9JxVlSRp4FrBuuBLdSePYAl-Utd8